Eric J. Mathur

Eric Mathur serves as Chief Science Officer of Diomics Corporation. His career spans over 40 years in basic & applied biotechnology with a focus on translational science. His expertise encompasses molecular biology, genome sciences, environmental microbiology, molecular diagnostics & high throughput drug discovery. A serial entrepreneur in the early San Diego biotech industry, Mathur participated in formation of several start-ups including Stratagene Cloning Systems (acquired by Agilent); Diversa Corporation (acquired by BASF & British Petroleum,) and Synthetic Genomics (spinout Agradis acquired by Monsanto), among others. He is an accomplished biotechnologist with 50+ peer reviewed publications and over 100 issued patents. Eric’s passion lies in leveraging genomics, biologics & polymer technologies to develop science-driven nutraceuticals, plant-based-medicines and modern therapeutics